Skip to main navigation
redirect to ADARx Pharmaceuticals corp site
  • News
  • Contact
  • Pipeline
  • Science
    • Overview
    • Technology
  • Patients
  • Company
    • Overview
    • Leadership
    • Board of Directors
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote and Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management Team
      • Committee Composition
    • Financial Information
      • SEC Filings
    • Shareholder Service
      • Investor FAQs
      • Contact Us
    • Email Alerts
  • Careers

Investor Relations

SEC Filing Details

Document Details

Form
8-K
Filing Date
Nov 12, 2026
Document Date
Nov 12, 2026
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
ADARx Pharmaceuticals
Issuer
ADARx Pharmaceuticals, Inc.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT
footer logo redirect to  ADARx Pharmaceuticals  corp site
  • Pipeline
  • Science
  • Patients
  • Company
  • Investors
  • Careers
  • News
  • Contact

Corporate Offices
5871 Oberlin Drive, Suite 200 
San Diego, CA 92121
info@adarx.com

© 2026 ADARx Pharmaceuticals | Privacy Policy

logo
  • Pipeline
  • Science
    • Overview
    • Technology
  • Patients
  • Company
    • Overview
    • Leadership
    • Board of Directors
    • Investors
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote and Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management Team
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Quarterly Results
      • Annual Reports
    • Shareholder Services
      • Investor FAQs
      • Email Alerts
      • Contact IR
  • Careers
  • News
  • Contact
Search Investors